IFX1
Bullish
now
$IFRX Complement activation may contribute to the maladaptive inflammatory response seen in some patients with severe COVID-19. Inhibition of C3 or C5 may have therapeutic potential. ARDS, acute respiratory distress syndrome nature.com/articles/s41577-...
  • 8
8 Likes